FOXO4-DRI 18 mg

FOXO4-DRI (18) Peptide — Senescence Pathway Research Tool (UK Supply)

FOXO4-DRI (18) is a high-purity, research-grade peptide designed for laboratory investigations into cellular senescence, protein–protein interactions, and signalling pathways associated with ageing models. In UK research environments, it is used in controlled in-vitro studies to examine how specific peptide sequences may influence cellular stress responses, regulatory signalling, and senescence-related communication pathways.

Prepared as a lyophilized peptide powder, FOXO4-DRI (18) is formulated for stability, consistent handling, and reproducible experimental outcomes, supporting advanced research across cellular biology, molecular signalling, and ageing-related pathway studies.

Key Facts About FOXO4-DRI (18)

Research Uses

FOXO4-DRI (18) is commonly applied in UK laboratory research for:

• Cellular senescence pathway investigations
• Protein–protein interaction studies
• Stress-response and signalling pathway modelling
• Ageing-related cellular communication research
• Comparative peptide sequence and functional analysis

Advantages for Laboratory Research

• Defined amino-acid sequence for precise experimental control
• High-purity formulation supporting reproducible results
• Stable lyophilized format suitable for long-term storage
• Compatible with advanced in-vitro senescence models
• Supports detailed investigation of ageing-related cellular pathways

Why Choose FOXO4-DRI (18) in the UK?

FOXO4-DRI (18) is selected by researchers for its structural precision and relevance in cellular ageing and senescence studies. Its defined peptide sequence allows for controlled experimentation into protein interactions and stress-response mechanisms under laboratory conditions.

In UK research settings, it is valued as a dependable tool for exploring senescence pathways, cellular regulation, and molecular signalling in ageing models.